About perspective therapeutics inc - CATX
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
CATX At a Glance
Perspective Therapeutics, Inc.
2401 Elliott Avenue
Seattle, Washington 98121
| Phone | 1-206-676-0900 | Revenue | 884.00K | |
| Industry | Medical Specialties | Net Income | -103,121,000.00 | |
| Sector | Health Technology | Employees | 166 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
CATX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 229.622 |
| Price to Book Ratio | 0.987 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.613 |
| Enterprise Value to Sales | 69.572 |
| Total Debt to Enterprise Value | 0.053 |
CATX Efficiency
| Revenue/Employee | 5,325.301 |
| Income Per Employee | -621,210.843 |
| Receivables Turnover | 0.851 |
| Total Asset Turnover | 0.003 |
CATX Liquidity
| Current Ratio | 5.174 |
| Quick Ratio | 5.174 |
| Cash Ratio | 5.047 |
CATX Profitability
| Gross Margin | -267.76 |
| Operating Margin | -11,715.385 |
| Pretax Margin | -11,813.122 |
| Net Margin | -11,665.271 |
| Return on Assets | -33.192 |
| Return on Equity | -41.646 |
| Return on Total Capital | -49.283 |
| Return on Invested Capital | -41.18 |
CATX Capital Structure
| Total Debt to Total Equity | 1.571 |
| Total Debt to Total Capital | 1.547 |
| Total Debt to Total Assets | 1.186 |
| Long-Term Debt to Equity | 1.243 |
| Long-Term Debt to Total Capital | 1.224 |